Aurobindo Pharma Ltd. (AUROPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 164981, "name": "Aurobindo Pharma", "stock_name": "Aurobindo Pharma", "full_name": "Aurobindo Pharma Ltd.", "name_url": "stocks-analysis/aurobindo-pharma", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "1,226.10", "chg": 55.1, "chgp": "4.71%", "dir": 1, "prev_price": "1,171.00", "mcapval": "71,442.00 Cr", "mcap": "Mid Cap", "scripcode": 524804, "symbol": "AUROPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE406A01037", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "30.96 lacs", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Aurobindo Pharma Ltd. Opens Strong with Significant Gap Up on 3 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3817632", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_gapup_3817632.png", "date": "2026-02-03 09:39:56", "description": "Aurobindo Pharma Ltd. commenced trading on 3 Feb 2026 with a notable gap up, opening 6.12% higher than its previous close, reflecting a robust start and positive market sentiment within the Pharmaceuticals & Biotechnology sector." }, { "title": "Aurobindo Pharma Ltd. Hits Intraday High with 5.05% Surge on 3 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-intraday-high-with-505-surge-on-3-feb-2026-3817539", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_priceRelatedfactors_3817539.png", "date": "2026-02-03 09:36:13", "description": "Aurobindo Pharma Ltd. demonstrated robust intraday strength on 3 Feb 2026, surging to an intraday high of Rs 1,247.05, marking a 6.12% gain from its previous close. The stock outperformed its sector and the broader market, reflecting strong buying momentum amid a mixed market backdrop." }, { "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Sideways Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-amid-sideways-trend-3815224", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_technicaldot_3815224.png", "date": "2026-02-02 08:00:26", "description": "Aurobindo Pharma Ltd. has witnessed a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend, reflecting a period of consolidation after recent volatility. Key technical indicators such as MACD, RSI, and moving averages reveal a nuanced picture of the stock’s near-term prospects amid broader market pressures." }, { "title": "Aurobindo Pharma Gains 6.98%: 3 Key Drivers Behind This Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-gains-698-3-key-drivers-behind-this-weeks-momentum-3814784", "imagepath": "", "date": "2026-02-01 15:01:12", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jan:</strong> Stock dips 0.26% amid broader Sensex gains</p>\n <p><strong>28 Jan:</strong> Recovery with 0.88% gain, Sensex up 1.12%</p>\n <p><strong>29 Jan:</strong> Continued gains of 0.91%, Sensex marginally up 0.22%</p>\n <p><strong>30 Jan:</strong> Sharp 5.37% rally on record volumes and derivatives surge</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,133.15</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,212.30</di..." }, { "title": "Aurobindo Pharma Ltd: Valuation Shift Signals Caution Amidst Mixed Market Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-valuation-shift-signals-caution-amidst-mixed-market-performance-3813515", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_valuationdot_3813515.png", "date": "2026-02-01 08:00:32", "description": "Aurobindo Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group." }, { "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3813483", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AurobindoPharma_technicaldot_3813483.png", "date": "2026-02-01 08:00:21", "description": "Aurobindo Pharma Ltd. has exhibited a notable shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a complex interplay of technical indicators. Despite mixed signals from key oscillators and moving averages, the stock’s recent performance and technical parameters suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Why is Aurobindo Pharma Ltd. falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aurobindo-pharma-ltd-fallingrising-3812195", "imagepath": "", "date": "2026-01-31 00:48:24", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Short-Term Performance Outpaces Benchmark</strong></p>\n<p>The stock has demonstrated impressive gains over the past week, appreciating by 5.37%, significantly outperforming the Sensex’s modest 0.90% rise during the same period. This recent surge is part of a broader trend, with the stock also posting a positive 0.57% return over the last month, while the Sensex declined by 2.84%. Year-to-date, Aurobindo Pharma has gained 1.08%, contrasting with the Sensex’s 3.46% fall. These figures underscore the stock’s resilience and relative strength amid broader market volatility.</p>\n<p><strong>Intraday Strength and Moving Averages Signal Positive Momentum</strong></p>\n<p>On 30-Jan, the stock opened with a gap up of 3.43%, signalling strong buying interest from the outset. It reached an intraday..." }, { "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Bullish Market Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-bullish-market-momentum-3811644", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AurobindoPharma_oi_spurts_by_underlying_3811644.png", "date": "2026-01-30 15:00:09", "description": "Aurobindo Pharma Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical major’s stock outperformed its sector peers, buoyed by strong volume and sustained buying interest, as traders recalibrate their directional bets amid evolving market dynamics." }, { "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Bullish Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-bullish-momentum-3811594", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AurobindoPharma_oi_spurts_by_underlying_3811594.png", "date": "2026-01-30 14:00:07", "description": "Aurobindo Pharma Ltd. has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector and broader indices, supported by robust volume and positive price action, prompting a reassessment of its market positioning and investor sentiment." } ], "total": 712, "sid": "164981", "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981" }, "announcements": [ { "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "28-Nov-2019" }, { "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "15-Nov-2019" }, { "details": "Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'.", "source": "NSE", "caption": "Aurobindo Pharma Limited - Updates", "datetime": "14-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "09 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25", "dt": "2025-08-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11", "dt": "2011-02-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15", "dt": "2015-07-20", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jan: Stock dips 0.26% amid broader Sensex gains

28 Jan: Recovery with 0.88% gain, Sensex up 1.12%

29 Jan: Continued gains of 0.91%, Sensex marginally up 0.22%

30 Jan: Sharp 5.37% rally on record volumes and derivatives surge

Week Open

Rs.1,133.15

Week Close

Rs.1,212.30Read full news article

Aurobindo Pharma Ltd: Valuation Shift Signals Caution Amidst Mixed Market Performance

2026-02-01 08:00:32

Aurobindo Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group.

Read full news article

Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-01 08:00:21

Aurobindo Pharma Ltd. has exhibited a notable shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a complex interplay of technical indicators. Despite mixed signals from key oscillators and moving averages, the stock’s recent performance and technical parameters suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Aurobindo Pharma Ltd. falling/rising?

2026-01-31 00:48:24

Robust Short-Term Performance Outpaces Benchmark

The stock has demonstrated impressive gains over the past week, appreciating by 5.37%, significantly outperforming the Sensex’s modest 0.90% rise during the same period. This recent surge is part of a broader trend, with the stock also posting a positive 0.57% return over the last month, while the Sensex declined by 2.84%. Year-to-date, Aurobindo Pharma has gained 1.08%, contrasting with the Sensex’s 3.46% fall. These figures underscore the stock’s resilience and relative strength amid broader market volatility.

Intraday Strength and Moving Averages Signal Positive Momentum

On 30-Jan, the stock opened with a gap up of 3.43%, signalling strong buying interest from the outset. It reached an intraday...

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amid Bullish Market Momentum

2026-01-30 15:00:09

Aurobindo Pharma Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical major’s stock outperformed its sector peers, buoyed by strong volume and sustained buying interest, as traders recalibrate their directional bets amid evolving market dynamics.

Read full news article

Aurobindo Pharma Sees Significant Open Interest Surge Amid Bullish Momentum

2026-01-30 14:00:07

Aurobindo Pharma Ltd. has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector and broader indices, supported by robust volume and positive price action, prompting a reassessment of its market positioning and investor sentiment.

Read full news article

View All News